215 related articles for article (PubMed ID: 10346868)
1. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
2. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J
Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030
[TBL] [Abstract][Full Text] [Related]
3. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
4. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.
Liu S; Edwards DS; Harris AR
Bioconjug Chem; 1998; 9(5):583-95. PubMed ID: 9736492
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
6. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
7. (99m)Tc-HYNIC-derivatized ternary ligand complexes for (99m)Tc-labeled polypeptides with low in vivo protein binding.
Ono M; Arano Y; Mukai T; Fujioka Y; Ogawa K; Uehara T; Saga T; Konishi J; Saji H
Nucl Med Biol; 2001 Apr; 28(3):215-24. PubMed ID: 11323230
[TBL] [Abstract][Full Text] [Related]
8. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification.
Takagi K; Uehara T; Kaneko E; Nakayama M; Koizumi M; Endo K; Arano Y
Nucl Med Biol; 2004 Oct; 31(7):893-900. PubMed ID: 15464391
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.
Ono M; Arano Y; Mukai T; Uehara T; Fujioka Y; Ogawa K; Namba S; Nakayama M; Saga T; Konishi J; Horiuchi K; Yokoyama A; Saji H
Nucl Med Biol; 2001 Feb; 28(2):155-64. PubMed ID: 11295426
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
Wang J; Kim YS; Liu S
Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
[TBL] [Abstract][Full Text] [Related]
12. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.
Liu S; Edwards DS; Looby RJ; Harris AR; Poirier MJ; Barrett JA; Heminway SJ; Carroll TR
Bioconjug Chem; 1996; 7(1):63-71. PubMed ID: 8741992
[TBL] [Abstract][Full Text] [Related]
13. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules.
Purohit A; Liu S; Ellars CE; Casebier D; Haber SB; Edwards DS
Bioconjug Chem; 2004; 15(4):728-37. PubMed ID: 15264859
[TBL] [Abstract][Full Text] [Related]
14. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of
Gan Q; Song X; Zhang X; Zhang J
Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
17. Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.
Surfraz MB; King R; Mather SJ; Biagini S; Blower PJ
J Inorg Biochem; 2009 Jul; 103(7):971-7. PubMed ID: 19447500
[TBL] [Abstract][Full Text] [Related]
18. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
19.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
Anticancer Agents Med Chem; 2018; 18(9):1295-1302. PubMed ID: 29521248
[TBL] [Abstract][Full Text] [Related]
20. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
Decristoforo C; Mather SJ
Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]